|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.7 TWD | -0.81% |
|
+0.69% | -4.05% |
BioGend Therapeutics Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 10.82 million compared to TWD 4.97 million a year ago. Net loss was TWD 51.23 million compared to TWD 44.63 million a year ago.
Basic loss per share from continuing operations was TWD 0.46 compared to TWD 0.43 a year ago. Diluted loss per share from continuing operations was TWD 0.46 compared to TWD 0.43 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.05% | 140M | |
| +46.13% | 54.63B | |
| -6.62% | 39.92B | |
| +37.07% | 38.82B | |
| +13.27% | 26.86B | |
| -11.17% | 26.22B | |
| -21.64% | 18.78B | |
| +25.56% | 12.21B | |
| +0.40% | 12.16B | |
| +25.74% | 11.94B |
BIOGEND THERAPEUTICS CO., LTD. 
